This regulatory mechanism promotes the progression of gastric cancer, and in vitro and in vivo experiments have confirmed the oncogenic role of the CCAT2/ESRP1/CD44 axis in promoting malignant behavior.18 Here, ESRP1 is linked to gastric cancer.